Hyster-Yale, Inc. (HY)
(Real Time Quote from BATS)
$61.28 USD
-0.52 (-0.84%)
Updated Sep 23, 2024 12:50 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Income Statements
Fiscal Year end for HysterYale, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 4,118 | 3,548 | 3,076 | 2,812 | 3,292 |
Cost Of Goods | 3,333 | 3,114 | 2,712 | 2,347 | 2,750 |
Gross Profit | 786 | 434 | 363 | 465 | 542 |
Selling & Adminstrative & Depr. & Amort Expenses | 577 | 473 | 516 | 416 | 488 |
Income After Depreciation & Amortization | 209 | -39 | -152 | 50 | 54 |
Non-Operating Income | 10 | 5 | 13 | 6 | 14 |
Interest Expense | 37 | 28 | 16 | 14 | 20 |
Pretax Income | 181 | -62 | -155 | 42 | 48 |
Income Taxes | 53 | 9 | 28 | 4 | 11 |
Minority Interest | 2 | 3 | -10 | 1 | 1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 128 | -72 | -183 | 39 | 37 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 126 | -74 | -173 | 37 | 36 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 255 | 6 | -47 | 95 | 99 |
Depreciation & Amortization (Cash Flow) | 47 | 45 | 105 | 45 | 45 |
Income After Depreciation & Amortization | 209 | -39 | -152 | 50 | 54 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 17.39 | 16.90 | 16.82 | 16.80 | 16.73 |
Diluted EPS Before Non-Recurring Items | 7.24 | -4.38 | -6.99 | 2.21 | 2.14 |
Diluted Net EPS (GAAP) | 7.24 | -4.38 | -10.29 | 2.21 | 2.14 |
Fiscal Year end for HysterYale, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 1,168.10 | 1,056.50 | 1,027.20 | 1,001.20 | 1,090.60 |
Cost Of Goods | 908.80 | 820.80 | 817.50 | 797.60 | 892.70 |
Gross Profit | 259.30 | 235.70 | 209.70 | 203.60 | 197.90 |
SG&A, R&D, and Dept/Amort Expenses | 163.70 | 151.90 | 161.00 | 145.00 | 139.10 |
Income After SG&A, R&D, and Dept/Amort Expenses | 95.60 | 83.80 | 48.70 | 58.60 | 58.80 |
Non-Operating Income | 3.20 | 2.00 | 2.10 | 3.60 | 0.40 |
Interest Expense | 8.80 | 8.90 | 9.10 | 9.60 | 8.40 |
Pretax Income | 90.00 | 76.90 | 41.70 | 52.60 | 50.80 |
Income Taxes | 26.10 | 25.10 | 16.00 | 16.20 | 12.00 |
Minority Interest | 0.60 | 0.30 | 0.50 | 0.60 | 0.50 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 63.90 | 51.80 | 25.70 | 36.40 | 38.80 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 63.30 | 51.50 | 25.20 | 35.80 | 38.30 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 17.66 | 17.59 | 17.57 | 17.41 | 17.31 |
Diluted EPS Before Non-Recurring Items | 3.58 | 2.93 | 1.43 | 2.06 | 2.21 |
Diluted Net EPS (GAAP) | 3.58 | 2.93 | 1.42 | 2.06 | 2.21 |